Confidentiality of IP. IP shall be deemed to be the Confidential Information of the party owning such IP. The protection of each party’s Confidential Information is described in Article 9. Any disclosure of information by one party to the other under the provisions of this Section 10 shall be treated as the disclosing party’s Confidential Information under this Agreement. It shall be the responsibility of the party preparing a patent application to obtain the written permission of the other party to use or disclose the other party’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.
Appears in 3 contracts
Samples: Drug Product Development and Clinical Supply Agreement (Bio-Path Holdings Inc), Company Plasmid Dna Production Agreement (Biocancell Therapeutics Inc.), Company Plasmid Dna Production Agreement (Biocancell Therapeutics Inc.)
Confidentiality of IP. IP shall be deemed to be the Confidential Information of the party owning such IP. The protection of each party’s Confidential Information is described in Article 918. Any disclosure of information by one party to the other under the provisions of this Section 10 Article 18 shall be treated as the disclosing party’s Confidential Information under this Agreement. It shall be the responsibility of the party preparing a patent application to obtain the written permission of the other party to use or disclose the other party’s Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.
Appears in 2 contracts
Samples: Commercial Supply Agreement (Amylin Pharmaceuticals Inc), Commercial Supply Agreement (Amylin Pharmaceuticals Inc)
Confidentiality of IP. IP shall be deemed to be the Confidential Information of the party owning such IP. The protection of each party’s 's Confidential Information is described in Article 9Section 11. Any disclosure of information by one party to the other under the provisions of this Section 10 12 shall be treated as the disclosing party’s 's Confidential Information under this Agreement. It shall be the responsibility of the party preparing a patent application to obtain the written permission of the other party party, which consent can not unreasonably be withheld, to use or disclose the other party’s 's Confidential Information in the patent application before the application is filed and for other disclosures made during the prosecution of the patent application.
Appears in 1 contract
Samples: Development and Supply Agreement (Halozyme Therapeutics Inc)
